Friends Research Institute, Inc.
Clinical trials sponsored by Friends Research Institute, Inc., explained in plain language.
-
Bridge to recovery: buprenorphine study aims to connect probationers to opioid treatment
Disease control TerminatedThis study tests whether giving a short-term buprenorphine treatment (called a bridge) to people on probation or parole with opioid use disorder helps them start and stay in community-based treatment. About 320 adults in Baltimore will either receive the bridge treatment or a ref…
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 26, 2026 05:40 UTC
-
Can a phone app help people beat opioid and cocaine addiction?
Disease control OngoingThis study tests whether a smartphone app can help people who are already on methadone treatment reduce their use of opioids and cocaine. About 240 adults who use both drugs will either get standard methadone care or also use an app that rewards them with money for drug-free test…
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 26, 2026 05:28 UTC
-
Jail telemedicine trial offers monthly shot to fight opioid relapse
Disease control OngoingThis study tests whether giving a long-acting buprenorphine shot (BRIXADI) via telemedicine to 30 jailed adults with opioid use disorder helps them stay on treatment after release. Participants switch from daily pills to weekly and then monthly injections before leaving jail, the…
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Jail-to-Community study tests monthly shots to fight opioid relapse
Disease control OngoingThis study compares two long-acting injectable medications—extended-release naltrexone and extended-release buprenorphine—for people with opioid use disorder who are leaving jail. About 240 participants from Maryland jails will receive one of the two medications monthly for six m…
Phase: PHASE2, PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 12, 2026 13:41 UTC